Statement attributable to: Jan K. Carney, MD, MPH, MACP President, American College of Physicians WASHINGTON, June 9, 2026—The American College of Physicians (ACP) is deeply concerned about the Office of Management and Budget’s proposed changes to the rules governing federal grants. The proposed rules would direct “senior appointees” at federal agencies to take charge of awarding and terminating new and existing research grants and other federal awards. As an organization with a mission to promote evidence-based medicine, we know the value of independent review by clinical and scientific…
PHILADELPHIA, June 9, 2026— Former American College of Physicians (ACP) President, Sandra A. Fryhofer, MD, MACP, was elected the American Medical Association (AMA) President-Elect at the AMA House of Delegates Annual Meeting in Chicago earlier today. Dr. Fryhofer will be AMA President-Elect 2026 to 2027 and will assume the role of AMA President the following year. “Dr. Fryhofer has been a strong advocate for internal medicine, physicians, and our patients for years,” said Jan K. Carney, MD, MPH, president, ACP. “With her background in public health, her work in vaccine advocacy, and her…
Statement attributable to: Jan K. Carney, MD, MPH, MACP President, American College of Physicians WASHINGTON June 8, 2026— The American College of Physicians is relieved by a federal judge’s decision to immediately stop the $100,000 fee that the Trump administration had imposed on H1-B visa applications, starting on Sept. 21, 2025, calling its implementation unlawful. The sudden imposition of this dramatically increased visa fee has been very difficult for employers of noncitizen medical residents and other international medical graduates to meet. International medical graduates are…
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results mcarmody Mon, 06/08/2026 - 08:49 Press release Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results NEW ORLEANS, La. June 8, 2026 Findings highlight potential to expand oral GLP-1 RA treatment options for patients with type 2 diabetes and obesity Findings from two phase 2 studies demonstrated positive outcomes for elecoglipron, an investigational oral, once-daily, small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA), in patients with type 2 diabetes…
The American Diabetes Association’s Statement Regarding Nonpartisanship mcarmody Sun, 06/07/2026 - 15:46 Official Statement The American Diabetes Association’s Statement Regarding Nonpartisanship ARLINGTON, Va. June 7, 2026 As many of you are now aware, an incident took place at the American Diabetes Association’s (ADA) Scientific Sessions. As a 501(c)(3) organization, the ADA has safeguards in place to ensure that it complies with all IRS regulations. This includes maintaining a strictly nonpartisan environment at all organizational events and functions while engaging across party…
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications mcarmody Sun, 06/07/2026 - 15:18 Press release Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications NEW ORLEANS, La. June 7, 2026 Embargoed until Sunday, June 7, 2026, at 4:30 p.m. CT Findings Demonstrate Potential for Amylin and GLP-1 Combinations as Next Generation of Weight Loss and Diabetes Treatment New international study findings demonstrated positive results of the first injectable glucagon-like peptide-1…
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes mcarmody Sun, 06/07/2026 - 13:28 Press release Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes NEW ORLEANS, La. June 7, 2026 Once-Monthly Injection Reduced Triglycerides and the Risk of Acute Pancreatitis; Bi-Weekly Injection Lowered “Bad” Cholesterol and Cardiovascular Events New data presented at the 2026 Scientific Sessions of the American Diabetes Association ® (ADA) demonstrate the benefits of using medications to address…
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health mcarmody Sun, 06/07/2026 - 06:28 Press release Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health NEW ORLEANS, La. June 7, 2026 Injectable Offers Potential to Reduce Fatty Liver Diseases and Improve Health Markers in Adults New data highlight the potential benefits of survodutide, a once-weekly injectable therapy targeting both the glucagon and glucagon-like peptide-1 (GLP-1) receptors in individuals with obesity and metabolic dysfunction-associated…
The American Diabetes Association Announces Winners of the Innovation Challenge mcarmody Sat, 06/06/2026 - 18:52 Press release The American Diabetes Association Announces Winners of the Innovation Challenge NEW ORLEANS, La. June 6, 2026 Today, from the main stage at the organization’s 2026 Scientific Sessions, the American Diabetes Association ® (ADA) announced the winners of the 2026 Innovation Challenge competition. Each year, the Innovation Challenge seeks game-changing ideas from emerging companies that have the potential to transform diabetes care. “There is tremendous…
These findings highlight the potential importance of identifying abnormal anthropometric characteristics in clinical settings to better capture individuals at risk for obesity-related health complications.
The American Diabetes Association’s Statement on the OMB’s Financial Assistance Proposed Rule vcramer Wed, 06/03/2026 - 14:58 Official Statement The American Diabetes Association’s Statement on the OMB’s Financial Assistance Proposed Rule Arlington, Va. June 3, 2026 The White House Office of Management and Budget (OMB) recently proposed a rewrite of the Guidance for Federal Financial Assistance, updating regulations that dictate reporting and performance requirements for federal grant recipients. The proposed rule implements many of the changes President Trump announced in an executive order…
The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge.
Statement attributable to: Jan K. Carney, MD, MPH, MACP President, American College of Physicians WASHINGTON June 1, 2026— The American College of Physicians is deeply concerned by the executive order that the administration issued on May 29, 2026, directing the U.S. Centers for Disease Control and Prevention (CDC) to alter the childhood vaccine schedule. This is the second time the administration has attempted to unilaterally substitute vaccine guidance from other countries to replace the U.S. vaccine schedule which was developed for the specific needs of the U.S. population. The U.S…
The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.
PHILADELPHIA, May 25, 2026—Private equity investment in health care requires increased regulatory oversight and policies to better protect patients and physicians from the adverse impact of growing corporate interests, says the American College of Physicians (ACP). In a new paper, “ Regulatory Framework for Private Equity and Corporatization in Health Care: A Position Paper from the American College of Physicians ,” published today in Annals of Internal Medicine , ACP examines the impact of private equity investment on clinical autonomy, health care costs, quality, access, equity, and…
Statement attributable to: Jan K. Carney, MD, MPH, MACP President, American College of Physicians WASHINGTON May 21, 2026— The American College of Physicians is alarmed by the abrupt firing of two members of the United States Preventive Services Task Force (USPSTF) this week. As primary care physicians, Dr. Wong and Dr. Davis serve as important representatives for internal medicine physicians and the patients that we care for. Both physicians are highly qualified experts, and we take issue with the lack of transparency in any review that Secretary Kennedy has conducted of members of the task…
ACP’s courses and course recordings are getting a branding makeover to make it easier for you to find the package or resource that best fits your needs.
PHILADELPHIA, May 11, 2026—Telemedicine can improve health equity by helping patients overcome barriers to in-person care, but meaningful policy changes are essential for lasting benefits, says the American College of Physicians (ACP). In a new paper, “ Telemedicine Policy and Practice: A Position Paper from the American College of Physicians ” published today in Annals of Internal Medicine , ACP issues recommendations for policymakers, regulators and health systems about how to improve telemedicine. ACP’s recommendations aim to ensure telemedicine is equitable, grounded in evidence, and used…
The U.S. Food and Drug Administration today issued a final guidance for industry, Postapproval Pregnancy Safety Studies, with recommendations on different methodologies that can be used in the postapproval setting to study the safety of drugs and biological products when used during pregnancy.